This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gilmour, S. K. Articles by O'Brien, T. G. Search for Related Content PubMed PubMed Citation Articles by Gilmour, S. K. Articles by O'Brien, T. G.

Regulation of Ornithine Decarboxylase Gene Expression in Mouse Epidermis and Epidermal Tumors during Two-Stage Tumorigenesis¹

The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania 19104 [S. K. G., T. M., T. G. O.]; and the Department of Human Oncology, University of Wisconsin Clinical Cancer Center, Madison, Wisconsin 53792 [A. K. V.]

Topical treatment of mouse skin with the potent tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) results in an array of biochemical alterations, one of the earliest being a more than 200-fold transient induction of epidermal ornithine decarboxylase (ODC) activity. There is an excellent correlation between the induction of epidermal ODC activity and changes in the level of immunoreactive ODC protein following a single TPA treatment to skin. Both ODC activity and protein levels peak at 4.5 h after TPA treatment and rapidly fall to basal levels by 24 h. Cycloheximide treatment of mice in which ODC had been previously induced by TPA indicated a similar rapid turnover of both ODC catalytic activity and protein levels. Northern blot analysis of polyadenylated RNA isolated from mouse epidermis after a single TPA treatment revealed the stimulation of one species of ODC mRNA of 2.0 kilobases with a maximum at 3.5 h declining by 16 h. The same-sized species of ODC mRNA was detected 4.5 h after multiple biweekly treatments with TPA as well as in mouse papillomas and carcinomas not treated with TPA for at least 1 week. Southern blot analysis of EcoRI or BamHI digests of DNA derived from mouse liver, papillomas, or carcinomas revealed no ODC gene amplification or rearrangement during neoplastic progression. These observations indicate that the induction of epidermal ODC activity following TPA treatment results in a transient increase in the steady state levels of ODC mRNA and in the rate of synthesis of ODC protein, in contrast to epidermal tumors where the levels of ODC mRNA and protein are constitutively elevated.

¹ This investigation was supported by Grants ES-01664, CA-09171, CA-35368, and CA-42585 from the National Institutes of Health.

² To whom requests for reprints should be addressed, at The Wistar Institute of Anatomy and Biology, 36th and Spruce Streets, Philadelphia, PA 19104.

Received 9/11/86. Revised 12/ 2/86. Accepted 12/ 4/86.

This article has been cited by other articles:

				Q. Ma, Y. Wang, X. Gao, Z. Ma, and Z. Song L-Arginine Reduces Cell Proliferation and Ornithine Decarboxylase Activity in Patients with Colorectal Adenoma and Adenocarcinoma Clin. Cancer Res., December 15, 2007; 13(24): 7407 - 7412. [Abstract] [Full Text] [PDF]

				S. M. Fischer, C. J. Conti, J. Viner, C.M. Aldaz, and R. A. Lubet Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against UV-induced skin tumors in mice Carcinogenesis, May 1, 2003; 24(5): 945 - 952. [Abstract] [Full Text] [PDF]

				R. K. Strair, D. Schaar, L. Goodell, J. Aisner, K.-V. Chin, J. Eid, R. Senzon, X. X. Cui, Z. T. Han, B. Knox, et al. Administration of a Phorbol Ester to Patients with Hematological Malignancies: Preliminary Results from a Phase I Clinical Trial of 12-O-Tetradecanoylphorbol-13-acetate Clin. Cancer Res., August 1, 2002; 8(8): 2512 - 2518. [Abstract] [Full Text] [PDF]

				S. M. Fischer, M. Lee, and R. A. Lubet Difluoromethylornithine is effective as both a preventive and therapeutic agent against the development of UV carcinogenesis in SKH hairless mice Carcinogenesis, January 1, 2001; 22(1): 83 - 88. [Abstract] [Full Text] [PDF]

				L. Lan, C. Trempus, and S. K. Gilmour Inhibition of Ornithine Decarboxylase (ODC) Decreases Tumor Vascularization and Reverses Spontaneous Tumors in ODC/Ras Transgenic Mice Cancer Res., October 1, 2000; 60(20): 5696 - 5703. [Abstract] [Full Text]

				K.-i. Mafune, Y. Tanaka, K. Mimori, M. Mori, K. Takubo, and M. Makuuchi Increased Expression of Ornithine Decarboxylase Messenger RNA in Human Esophageal Carcinoma Clin. Cancer Res., December 1, 1999; 5(12): 4073 - 4078. [Abstract] [Full Text] [PDF]

				J. M. Arbeit, R. R. Riley, B. Huey, C. Porter, G. Kelloff, R. Lubet, J. M. Ward, and D. Pinkel Difluoromethylornithine Chemoprevention of Epidermal Carcinogenesis in K14-HPV16 Transgenic Mice Cancer Res., August 1, 1999; 59(15): 3610 - 3620. [Abstract] [Full Text] [PDF]

				S. Gupta, N. Ahmad, R. R. Mohan, M. M. Husain, and H. Mukhtar Prostate Cancer Chemoprevention by Green Tea: In Vitro and in Vivo Inhibition of Testosterone-mediated Induction of Ornithine Decarboxylase Cancer Res., May 1, 1999; 59(9): 2115 - 2120. [Abstract] [Full Text] [PDF]

				R. R. Mohan, A. Challa, S. Gupta, D. G. Bostwick, N. Ahmad, R. Agarwal, S. R. Marengo, S. B. Amini, F. Paras, G. T. MacLennan, et al. Overexpression of Ornithine Decarboxylase in Prostate Cancer and Prostatic Fluid in Humans Clin. Cancer Res., January 1, 1999; 5(1): 143 - 147. [Abstract] [Full Text] [PDF]

				L. J. Shore, A. P. Soler, and S. K. Gilmour Ornithine Decarboxylase Expression Leads to Translocation and Activation of Protein Kinase CK2 in Vivo J. Biol. Chem., May 9, 1997; 272(19): 12536 - 12543. [Abstract] [Full Text] [PDF]